Preimplantation Genetic Screening, or PGS, is also known as aneuploidy screening. PGS is a common treatment for women who have a history of miscarriage. Aneuploidy (either missing or additional chromosomes), is frequently a factor in cases where embryos do not implant in a woman’s uterus
While still considered experimental by the American Society of Reproductive Medicine, this testing has proven to increase the chances of having a successful pregnancy. Additional costs for this service will be discussed in detail with you by one of our billing coordinators before you decide to proceed with the testing.
Preimplantation Genetic Diagnosis (PGD)
Preimplantation Genetic Diagnosis, or PGD, allows the screening of a single cell from embryos to determine whether genetic disorders or chromosomal abnormalities exist. By identifying abnormal embryos, we can ensure that only unaffected embryos are transferred back into the patient. This increases the chances of having a healthy baby. This testing is typically recommended when one or both prospective parents are carriers of genetic disorders.*
*While there are additional charges associated with this type of testing, it does increase chances of pregnancy, and may be recognized by your insurance as a covered service for reasons of medical necessity in some cases.